Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Lupus erythematoso systemic network and registry

Study ID: NCT07175610
Start Date: 2025-09-30
End Date: 2035-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment
Sponsor

Italian society of allergology, asthma and clinical immunology

Source: clinicaltrials.gov

Share:
Add to list

Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study

Study ID: NCT07001371
Start Date: 2025-12
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

Emotional Brain Training

Standard addiction counseling and medical therapy

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Serial Multisite Image-guided Biopsy to Study Breast Cancer Evolution

Study ID: NCT07084571
Start Date: 2025-09-30
End Date: 2040-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

Royal Marsden NHS Foundation Trust

Source: clinicaltrials.gov

Share:
Add to list

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

Study ID: NCT06999109
Start Date: 2027-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

TEAM-LEADS

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Cohort Study on Anti-microbial Stewardship in PICU

Study ID: NCT05862688
Start Date: 2025-10-01
End Date: 2026-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

antimicrobial therapy

Sponsor

Children's Hospital of Fudan University

Source: clinicaltrials.gov

Share:
Add to list

CHIME: Comparing Health Interventions for Maternal Equity

Study ID: NCT06724172
Start Date: 2026-04-01
End Date: 2030-04-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

795

Intervention / Treatment

Self-Management

Community-Based

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Study ID: NCT07172971
Start Date: 2026-02-01
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

10

Intervention / Treatment

SGLT-2 inhibitor

SGLT2 inhibitor

Sponsor

Larry W. Markham

Source: clinicaltrials.gov

Share:
Add to list

A Study of Donanemab, RG6289, or the Combination of Donanemab and RG6289 in Presenilin 1 (PSEN1) E280A Mutation Carriers for the Treatment of Autosomal-Dominant Alzheimer's Disease

Study ID: NCT06996730
Start Date: 2026-01-15
End Date: 2030-06-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Donnemab

RG6289

Donnemab placebo

RG6289 placebo

Sponsor

Banner Health

Source: clinicaltrials.gov

Share:
Add to list

Home-based Pulmonary Rehabilitation for COPD Patients

Study ID: NCT04820257
Start Date: 2026-02-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Home based exercise

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

Study ID: NCT07167277
Start Date: 2025-10
End Date: 2026-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Whey Protein

Placebo

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list